
|Articles|January 31, 2019
Eversana Reveals new Market Access Portfolio
Advertisement
Eversana, an independent provider of global services to the life sciences industry, annouced Health Strategies Insights by Eversana, a market access research and insights portfolio to help life sciences innovators make more informed decisions throughout the product lifecycle.
“The evolution of our market intelligence capabilities strengthens Eversana's growing life science platform,” said Rod Cavin, General Manager for Health Strategies Insights by Eversana. “The product portfolio provides valuable market access insights to leading global biopharmaceutical companies in various phases of product development across a number of therapeutic areas-helping our clients achieve commercial success.”
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5




